Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit (scientific article (publication date: September 2012))

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Q24595802

How to improve R&D productivity: the pharmaceutical industry's grand challenge

Q28314992

Creating a transatlantic research enterprise for preventing Alzheimer's disease

Q28731473

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Q29547554

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Q29614406

Design of comprehensive Alzheimer's disease centers to address unmet national needs

Q33742825

Cognition, aging, and disabilities: conceptual issues

Q33875434

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Q34065449

Overdiagnosis in cancer

Q34111655

Comorbidity in Aging and Dementia: Scales Differ, and the Difference Matters

Q34233250

Developing a national strategy to prevent dementia: Leon Thal Symposium 2009.

Q34984743

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Q34988061

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

Q37008887

A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.

Q37425789

Biomarkers and surrogate end points--the challenge of statistical validation

Q37724573

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

Q37952021

The draft "National Plan" to address Alzheimer's disease - National Alzheimer's Project Act (NAPA).

Q39623102

Pedro Cuatrecasas

Q48486927

Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010.

Q51016539

Revising the definition of Alzheimer's disease: a new lexicon.

Q53313597

The Nevada Vital Aging Initiative: A private-public partnership to study early predictors of dementia

Q57318379

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

nervous system development

Q1345738

Alzheimer's disease

Q11081

P304

page(s)

445-52

P577

publication date

2012-09-01

P1433

published in

Alzheimer's and Dementia

Q15750965

P1476

title

Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit

P478

volume

Reverse relations

cites work (P2860)

Q48034789	A reduction in DNA damage in neural tissue and peripheral blood of old mice treated with caffeine.
Q38087640	Alzheimer's disease drug development: translational neuroscience strategies
Q35792042	Amyloid-β immunization enhances neurogenesis and cognitive ability in neonatal mice.
Q37679646	An Education Intervention to Enhance Staff Self-Efficacy to Provide Dementia Care in an Acute Care Hospital in Canada: A Nonrandomized Controlled Study
Q92784324	Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia
Q35664387	Attitudes and preferences towards screening for dementia: a systematic review of the literature
Q27012801	Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs
Q42319729	Cerebrovascular pathology and Alzheimer's disease
Q34465295	Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review
Q55456183	Computer-Aided Multi-Target Management of Emergent Alzheimer's Disease.
Q37476703	Dementia care management: going new ways in ambulant dementia care within a GP-based randomized controlled intervention trial
Q40088107	Depressive symptoms and depression in people screened positive for dementia in primary care - results of the DelpHi-study
Q34852407	Economic analysis of opportunities to accelerate Alzheimer's disease research and development
Q50663391	Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study.
Q91966476	Prioritäten der Pflegeforschung für das Themenfeld "Dementia Care" im deutschsprachigen Raum
Q37626382	Progress update: fluid and imaging biomarkers in Alzheimer's disease
Q30244419	Research priorities to reduce the global burden of dementia by 2025.
Q33600053	The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease
Q90596730	The value of the GP's clinical judgement in predicting dementia: a multicentre prospective cohort study among patients in general practice
Q47136427	Validation of the Argentine version of the Memory Binding Test (MBT) for Early Detection of Mild Cognitive Impairment.
Q48917074	Validation of the Chinese version of Addenbrooke's cognitive examination-revised for screening mild Alzheimer's disease and mild cognitive impairment